Highlights Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-07-15 EDT			5-day change	1st Jan Change
13.43 ^CNY	-2.11%		-3.80%	-8.27%

05-15	Han Yanzhen signed share transfer agreement to acquire 10.03% stake in Cisen Pharmaceutical Co., Ltd. from Beihai Chenxin Venture Capital Co., Ltd. for approximately CNY 680 million.	CI
04-23	Cisen Pharmaceutical Names Chief Financial Officer	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Han Yanzhen signed share transfer agreement to acquire 10.03% stake in Cisen Pharmaceutical Co., Ltd. from Beihai Chenxin Venture Capital Co., Ltd. for approximately CNY 680 million.	05-14	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	12-01	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	23-06-09	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22-11-22	MT
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	22-11-17	MT
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-17	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	21-12-30	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Sichuan Kelun Pharmaceutical Co., Ltd. completed the acquisition of 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership).	21-09-13	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-18	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. entered into an agreement to acquire 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke for approximately CNY 350 million.	21-07-28	CI
Sichuan Kelun Pharmaceutical Co., Ltd. agreed to acquire 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership) for approximately CNY 580 million.	21-07-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

Highlights

Filters